← Back to Search

Treatment for Atrial Fibrillation (ADVENT LTO Trial)

N/A
Waitlist Available
Led By Vivek Reddy
Research Sponsored by Boston Scientific Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 day-3 years
Awards & highlights
No Placebo-Only Group

Summary

The (ADVENT LTO) is an observational, non-significant risk study to assess the progression of atrial fibrillation in subjects who received ablation treatment with either the FARAPULSE Pulsed Field Ablation System or thermal ablation in the ADVENT Trial.

Eligible Conditions
  • Atrial Fibrillation

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 day-3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 day-3 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Chronic success in ADVENT Trial treated subjects compared between treatment groups.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Find a Location

Who is running the clinical trial?

Boston Scientific CorporationLead Sponsor
741 Previous Clinical Trials
856,318 Total Patients Enrolled
75 Trials studying Atrial Fibrillation
32,574 Patients Enrolled for Atrial Fibrillation
Vivek ReddyPrincipal InvestigatorMOUNT SINAI HOSPITAL
1 Previous Clinical Trials
669 Total Patients Enrolled
1 Trials studying Atrial Fibrillation
669 Patients Enrolled for Atrial Fibrillation
~389 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top